Breakthrough new generation technology for cervical cancer screening that directly detects cancer cells and cervical cancer lesions.

Unlike traditional cervical cancer screening methods (TCT and HPV) that detect abnormal cells or HPV virus, our test assay directly identifies cancerous cells and cervical cancer lesions through E7 oncoprotein detection.

• 15-minute rapid test - no need to wait for lab results
• Higher accuracy for cervical cancer screening
• Self-sampling cervical brush technology
• First rapid test kit worldwide to directly detect E7 oncoprotein
• Identifies high-grade precancerous lesions before progression to cancer

When E7 oncoprotein is expressed in large quantities, it causes cells to develop high-grade precancerous lesions until cancerous. Detection of E7 helps evaluate cervical precancerous lesions.

• Pap/TCT tests result in ASC-US population with abnormal cells but cannot detect cervical cancer cells and lesions
• DNA tests provide HPV virus infection and types but cannot detect cervical cancer cells and lesions
• E7 oncoprotein tests detect HPV-infected cells that become cancerous and directly identify oncoprotein expression
• Chinese FDA registered, EU registered, and CE marked
• Patented technology in China, USA, and other countries

Direct Detection: Use E7 oncoprotein rapid kit at hospitals, clinics, or for home testing to detect cervical cancer.

Combined with TCT/Pap Smear: Use E7 to further evaluate precancerous progression when only TCT testing is available.

Combined with HPV DNA Test: Improves diagnosis specificity of cervical lesions and provides referral basis for colposcopy.

For Positive TCT/HPV DNA Patients: Identify transient infections and assess disease progression risk.

Post-Surgery Patients: Assess recurrence risk and prognosis.

For Negative TCT/HPV DNA Patients: Detect lesions to avoid missed diagnosis when DNA tests show weak or false negatives.

Cervical Exfoliated Cell Sample Extraction:

• Use sampling cervical brush placed on transformation zone of cervix
• Turn clockwise six times
• Insert brush into test tube containing sample release agent

• Avoid intravaginal medicines, douching
• Avoid menstrual periods - no sampling three days before/after menstruation
• Do not sample during pregnancy